Exploring the Interplay between Endothelial Cells and Immune Cells in the Pathogenesis of Metabolic Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 312
Special Issue Editors
Interests: tumor microenvironment; blood vessels; immunotherapy; drug delivery and mechanism; metabolic reprogramming; chemoresistance; inflammation
Special Issue Information
Dear Colleagues,
The aim of this Special Issue is to provide a platform for communication and discussion in the field of pharmacology and the techniques currently applied to target metabolic syndromes, with a particular focus on the discovery of innovative drugs that target the vascular endothelium and immune cell interaction. We eagerly look forward to receiving submissions that advance our knowledge in this exciting area of research.
We encourage the submission of papers that attend to a wide array of topics, including but not limited to, the following: the impact of remodeling vasculature on drug delivery efficacy, the use of extracellular vesicle-based therapy, the drug targeting of radiotherapy-induced damage, the application of chemotherapy and immunotherapy, the drug targeting of metabolic changes in the metabolic/ tumor microenvironment, and the mechanism of action of innovative drugs. Both basic and clinical research contributions that address these topics are very welcome.
Dr. Kenneth Chat Pan Cheung
Dr. Rodrigo A. Loiola
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tumor microenvironment
- blood vessels
- immunology
- immunotherapy
- drug delivery and mechanism
- metabolic reprogramming
- chemoresistance
